Ispaghula

Ispaghula consists of dried ripe seeds of Plantago Ovata, Ispaghula is a purgative. Ispaghula adsorbs water and increases the faecal bulk and promotes bowel movement.


Brands
Adult Dose
Dose: 3000 to 5000 mg
Single Dose: 4000 (4000)
Frequency: 12 hourly
Route: PO
Instructions: For 2-3 Days
Neonatal
Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group
Paedriatic
Dose: 300 mg/kg
Single Dose: 300 (300)
Frequency: 12 hourly
Route: Oral
Instructions: As Required
Characteristics
Ispaghula also known as Psyllium, Psyllium. . It is of Natural origin. It belongs to Laxatives pharmacological group on the basis of mechanism of action.
Contraindications
Ispaghula is contraindicated in conditions like Intestinal obstruction.
Effects
The severe or irreversible adverse effects of Ispaghula, which give rise to further complications include Renal pigmentation.Ispaghula produces potentially life-threatening effects which include Anaphylactic shock, Bronchospasm, Rhinitis. which are responsible for the discontinuation of Ispaghula therapy.The signs and symptoms that are produced after the acute overdosage of Ispaghula include Abdominal pain, Intestinal obstruction, Abdominal distension, Flatulence.The symptomatic adverse reactions produced by Ispaghula are more or less tolerable and if they become severe, they can be treated symptomatically, these include Flatulence, Abdominal pain.
Indications
Ispaghula is primarily indicated in conditions like Constipation, Irritable bowel syndrome, Strainous defaecation, and can also be given in adjunctive therapy as an alternative drug of choice in Chronic renal failure, Hypercholesterolaemia.
Interactions
No data regarding the interactions of Ispaghula was found.
Interfrence
Risks
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Powder Store Below 40°C. Protect from Sunlight and Moisture.
Warnings
Bulk laxative (ispaghula) should not be given to patients with pre-existing fecal impaction, intestinal obstruction or colonic atony. They should be taken with sufficient fluid and should not be taken immediately before going to bed. They should be avoided to patients who have difficult swallowing. It should be used with caution (if contains tartrazine) in patients with aspirin hypersensitivity, because may cause allergic reactions (including bronchial asthma). Discontinue use if skin eruption occurs.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.